المؤلفون: Naderi E; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.; Center for Statistical Genetics, Gertrude H. Sergievsky Center, and the Department of Neurology, Columbia University Medical Center, New York, NY, USA., Aguado-Barrera ME; Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain., Schack LMH; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Gødstrup Hospital, Herning, Denmark.; NIDO | Centre for Research and Education, Gødstrup Hospital, Herning, Denmark., Dorling L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Rattay T; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Fachal L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Summersgill H; Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK., Martínez-Calvo L; Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain., Welsh C; Department of Oncology, University of Cambridge, Cambridge, UK., Dudding T; Bristol Dental School, University of Bristol, Bristol, UK.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK., Odding Y; Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Varela-Pazos A; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Jena R; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK., Thomson DJ; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Steenbakkers RJHM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Lobato-Busto R; Department of Medical Physics, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Ness A; Bristol Dental School, University of Bristol, Bristol, UK., Nutting C; Head and Neck Unit, The Royal Marsden Hospital, London, UK., Gómez-Caamaño A; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Eriksen JG; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Thomas SJ; Bristol Dental School, University of Bristol, Bristol, UK., Bates AM; Department of Oncology, University of Cambridge, Cambridge, UK., Webb AJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK., Choudhury A; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK., Rosenstein BS; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Taboada-Valladares B; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Herskind C; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Azria D; Fédération Universitaire d'Oncologie Radiothérapie d'Occitanie Méditérranée, Département d'Oncologie Radiothérapie, ICM Montpellier, INSERM U1194 IRCM, University of Montpellier, Montpellier, France., Dearnaley DP; Division of Radiotherapy and Imaging, The Institute of Cancer Research Department, The Royal Marsden NHS Foundation Trust, London, UK., de Ruysscher D; MAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands., Sperk E; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Stobart H; Patient Advocate, Independent Cancer Patients' Voice, London, UK., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., De Ruyck K; Departments of Basic Medical Sciences and Radiotherapy, Ghent University Hospital, Ghent, Belgium., Veldeman L; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium., Altabas M; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., De Santis MC; Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Farcy-Jacquet MP; Fédération Universitaire d'Oncologie Radiothérapie d'Occitanie Méditérranée, Département d'Oncologie Radiothérapie, CHU Carémeau, Nîmes, France., Veldwijk MR; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Parliament M; Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Usmani N; Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Burnet NG; The Christie NHS Foundation Trust, Manchester, UK., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany., Symonds RP; Cancer Research Centre, University of Leicester, Leicester, UK., Elliott RM; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK., Bultijnck R; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium., Gutiérrez-Enríquez S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain., Mollà M; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Gulliford SL; Department of Medical Physics and Biomedical Engineering, University College London, UK., Green S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rancati T; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Reyes V; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Carballo A; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Peleteiro P; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Sosa-Fajardo P; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Parker C; Department of Medical Physics and Biomedical Engineering, University College London, UK., Fonteyne V; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium., Johnson K; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Lambrecht M; Radiation Oncology, KU Leuven, Leuven, Belgium., Vanneste B; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.; Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Valdagni R; Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giraldo A; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Ramos M; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Diergaarde B; Department of Human Genetics, School of Public Health, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Liu G; Princess Margaret Cancer Centre, Temerty Faculty of Medicine, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Leal SM; Center for Statistical Genetics, Gertrude H. Sergievsky Center, and the Department of Neurology, Columbia University Medical Center, New York, NY, USA.; Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA., Chua MLK; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Oncology Academic Clinical Programme, Singapore., Pring M; Bristol Dental School, University of Bristol, Bristol, UK., Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Cascallar-Caneda LM; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Duprez F; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium., Talbot CJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK., Barnett GC; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Vega A; Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.; Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras, Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Andreassen CN; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., West CML; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK., Alizadeh BZ; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands., Kerns SL; Department of Radiation Oncology, The Medical College of Wisconsin, Milwaukee, WI, USA.

مؤلفون مشاركون: Radiogenomics Consortium

المصدر: JNCI cancer spectrum [JNCI Cancer Spectr] 2023 Oct 31; Vol. 7 (6).

نوع المنشور: Meta-Analysis; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE

مواضيع طبية MeSH: Genome-Wide Association Study* , Neoplasms*/genetics , Neoplasms*/radiotherapy, Male ; Humans ; Breast ; Genetic Predisposition to Disease

المؤلفون: Naderi E; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands; Department of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: b.z.alizadeh@umcg.nl., Schack LMH; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Oncology, Regional Hospital West Jutland, Gødstrup, Denmark., Welsh C; Department of Oncology, University of Cambridge, Cambridge, UK., Sim AYL; Division of Radiation Oncology, Dept of Head and Neck and Thoracic Cancers, Duke-NUS Medical School, Singapore, Singapore; Division of Medical Sciences, National Cancer Centre, Singapore., Aguado-Barrera ME; Fundación Pública Galega Medicina Xenómica (FPGMX), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Dudding T; Bristol Dental School, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK., Summersgil H; Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK., Martínez-Calvo L; Fundación Pública Galega Medicina Xenómica (FPGMX), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Ong EHW; Division of Medical Sciences, National Cancer Centre, Singapore., Odding Y; University Hospitals Bristol and Weston, Bristol, UK., Varela-Pazos A; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Steenbakkers RJHM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Crijns APG; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Jena R; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK., Pring M; Bristol Dental School, University of Bristol, Bristol, UK., Dennis J; Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Lobato-Busto R; Department of Medical Physics, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Ness A; Bristol Dental School, University of Bristol, Bristol, UK., Nutting C; Head and Neck Unit, The Royal Marsden Hospital, London, UK., Thomson DJ; Christie Hospital NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Gómez-Caamaño A; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Eriksen JG; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Thomas SJ; Bristol Dental School, University of Bristol, Bristol, UK., Bates AM; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK., Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Cascallar-Caneda LM; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Duprez F; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Barnett GC; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK., Dorling L; Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Chua MLK; Division of Radiation Oncology, Dept of Head and Neck and Thoracic Cancers, Duke-NUS Medical School, Singapore, Singapore; Division of Radiation Oncology, National Cancer Centre, Singapore., Vega A; Fundación Pública Galega Medicina Xenómica (FPGMX), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain., West CML; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Nicolaj Andreassen C; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Alizadeh BZ; Department of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: b.z.alizadeh@umcg.nl.

مؤلفون مشاركون: On the behalf of the Radiogenomics Consortium

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Nov; Vol. 176, pp. 138-148. Date of Electronic Publication: 2022 Sep 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Deglutition Disorders* , Mucositis* , Head and Neck Neoplasms*/genetics , Head and Neck Neoplasms*/radiotherapy , Head and Neck Neoplasms*/complications , Radiation Injuries*, Humans ; Genome-Wide Association Study ; Genetic Predisposition to Disease ; Polymorphism, Single Nucleotide

المؤلفون: Schack LMH; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. schack@oncology.au.dk.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. schack@oncology.au.dk., Naderi E; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands., Fachal L; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Dorling L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Ong EHW; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Chua MLK; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore., Langendijk JA; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands., Alizadeh BZ; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands., Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Eriksen JG; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Andreassen CN; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

مؤلفون مشاركون: Head and Neck Group of the Radiogenomics Consortium, Danish Head and Neck Cancer Group (DAHANCA)

المصدر: British journal of cancer [Br J Cancer] 2022 Apr; Vol. 126 (7), pp. 1082-1090. Date of Electronic Publication: 2022 Jan 17.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Head and Neck Neoplasms*/genetics , Head and Neck Neoplasms*/radiotherapy , Mucositis* , Radiation Oncology*, Genome-Wide Association Study ; Humans

المؤلفون: Andreassen CN; Department of Oncology, Aarhus University Hospital, Denmark; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: nicolaj@oncology.au.dk., Eriksen JG; Department of Oncology, Aarhus University Hospital, Denmark; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Jensen K; Department of Oncology, Aarhus University Hospital, Denmark; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Hansen CR; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark; Laboratory of Radiation Physics, Odense University Hospital, Denmark; Institute of Clinical Research, University of Southern Denmark, Denmark., Sørensen BS; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Lassen P; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Schack LMH; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Grau C; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.

المصدر: Oral oncology [Oral Oncol] 2018 Nov; Vol. 86, pp. 91-99. Date of Electronic Publication: 2018 Sep 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Head and Neck Neoplasms/*therapy , Precision Medicine/*methods , Radiation Injuries/*prevention & control , Radiotherapy, Intensity-Modulated/*methods, Antineoplastic Agents, Immunological/therapeutic use ; Cetuximab/therapeutic use ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; Chromosome Aberrations ; Dose-Response Relationship, Radiation ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/mortality ; Humans ; Precision Medicine/adverse effects ; Prognosis ; Radiation Injuries/etiology ; Radiation Tolerance/genetics ; Radiation Tolerance/radiation effects ; Radiotherapy Dosage ; Radiotherapy, Intensity-Modulated/adverse effects ; Survival Analysis ; Treatment Outcome

المؤلفون: Schack LMH; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark., Petersen SE; b Department of Oncology , Aarhus University Hospital , Aarhus , Denmark., Nielsen S; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark., Lundby L; c Department of Surgery , Aarhus University Hospital , Aarhus , Denmark., Høyer M; d Danish Centre for Particle Therapy , Aarhus University Hospital , Aarhus , Denmark., Bentzen L; b Department of Oncology , Aarhus University Hospital , Aarhus , Denmark., Overgaard J; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark., Andreassen CN; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark.; b Department of Oncology , Aarhus University Hospital , Aarhus , Denmark., Alsner J; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark.

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2017 Nov; Vol. 56 (11), pp. 1514-1521. Date of Electronic Publication: 2017 Aug 26.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Polymorphism, Single Nucleotide*, Biomarkers, Tumor/*genetics , Neoplasm Recurrence, Local/*radiotherapy , Prostatic Neoplasms/*radiotherapy , Radiation Injuries/*diagnosis , Radiotherapy/*adverse effects, Aged ; Aged, 80 and over ; Cohort Studies ; Genetic Predisposition to Disease ; Humans ; Male ; Middle Aged ; Morbidity ; Neoplasm Recurrence, Local/genetics ; Prostatic Neoplasms/genetics ; Quality of Life ; Radiation Injuries/etiology ; Transcriptome